Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Steril-Gene Life Sciences is a leading Indian contract development and manufacturing organization (CDMO) that provides comprehensive pharmaceutical manufacturing services. The company is a joint venture between the Madras Pharmaceuticals group and Lloyd Laboratories, leveraging extensive expertise in the generic drug market. Their state-of-the-art manufacturing facility in Puducherry is equipped to produce a wide array of dosage forms, including oral solids, liquids, and specialized injectables. Steril-Gene maintains high quality standards with certifications from global regulatory bodies such as the USFDA, UK MHRA, and Australian TGA. The company's product portfolio covers diverse therapeutic segments including anti-infectives, cardiovascular health, and gastroenterology. By offering both development and large-scale production capabilities, Steril-Gene serves as a critical partner for global pharmaceutical companies seeking reliable supply chain solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Steril-Gene Life Sciences.